CPT® Code 80420

1. Indications

The dexamethasone suppression panel is indicated for the evaluation of adrenal gland function, particularly in the context of suspected Cushing syndrome. The following conditions may warrant the performance of this test:

• Cushing Syndrome A condition characterized by excessive cortisol production, which may present with symptoms such as weight gain, hypertension, and glucose intolerance.
• Adrenal Gland Disorders Conditions affecting adrenal function, which may lead to abnormal cortisol levels and require further investigation.
• ACTH-Dependent Hypercortisolism Situations where the adrenal glands are stimulated by adrenocorticotropic hormone, necessitating assessment of cortisol suppression.

2. Procedure

The procedure for the dexamethasone suppression panel involves several critical steps to ensure accurate measurement of cortisol levels. The following steps outline the process:

• Step 1: Initial Urine Collection The test begins with a 24-hour urine collection, which starts after the first morning void. Patients are instructed to collect all urine produced during this period, ensuring that the urine is refrigerated to maintain its integrity. At the end of the 24-hour collection, the urine is labeled with the collection time and date before being sent to the laboratory for volume measurement and testing of free cortisol levels.
• Step 2: Baseline Blood Sample A baseline blood sample is obtained through a separately reportable venipuncture to measure cortisol levels prior to the administration of dexamethasone. This step is crucial for establishing a reference point for subsequent cortisol measurements.
• Step 3: Administration of Dexamethasone Patients are administered oral dexamethasone at a dosage of 2 mg every 6 hours for a total duration of 48 hours. This medication is essential for suppressing cortisol production and is taken while continuing the urine collection.
• Step 4: Final Urine Collection During the 48-hour period, urine collection continues, and it is imperative that the urine remains refrigerated. Six hours after the last dose of dexamethasone, a final blood sample is obtained through a separately reportable venipuncture to measure cortisol levels. The last voided urine is then added to the 48-hour urine collection.
• Step 5: Laboratory Testing The completed urine collection is labeled with the final collection time and date before being sent to the laboratory. The urine is tested for cortisol levels using quantitative liquid chromatography-tandem mass spectrometry, while serum or plasma samples are analyzed for cortisol using quantitative chemiluminescent immunoassay.

3. Post-Procedure

After the completion of the dexamethasone suppression panel, patients may resume their normal activities. It is important to monitor for any potential side effects from the dexamethasone administration, although these are typically minimal when used in this controlled setting. The results of the test will be analyzed by the healthcare provider, who will discuss the findings with the patient and determine the next steps in diagnosis or treatment based on the cortisol levels obtained from both urine and blood samples. Follow-up appointments may be necessary to review results and consider further testing or interventions if indicated.